A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain
NCT00323102
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
114
Enrollment
INDUSTRY
Sponsor class
Conditions
Brain Pathology
Interventions
DRUG:
Multihance
Sponsor
Bracco Diagnostics, Inc